Nicox Ophthalmics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $120M

Nicox Ophthalmics General Information

Description

Developer of an ophthalmic therapeutics treatment. The company focuses on developing products to treat an ocular eye diseases.

Contact Information

Website
www.aciexrx.com
Formerly Known As
Aciex Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 470 Atlantic Avenue
  • 4th floor
  • Boston, MA 02210
  • United States
+1 (508)
Primary Industry
Drug Discovery
Acquirer
Nicox
Vertical(s)
Life Sciences
Corporate Office
  • 470 Atlantic Avenue
  • 4th floor
  • Boston, MA 02210
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nicox Ophthalmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 28-Oct-2014 $120M Completed Generating Revenue
4. Later Stage VC 22-Apr-2014 Completed Generating Revenue
3. Early Stage VC (Series B) 11-Aug-2011 Completed Generating Revenue
2. Early Stage VC (Series A2) 01-Feb-2009 $3.76M $37.7M Completed Product Development
1. Early Stage VC (Series A1) 21-Sep-2007 $34M $34M Completed Product Development
To view Nicox Ophthalmics’s complete valuation and funding history, request access »

Nicox Ophthalmics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an ophthalmic therapeutics treatment. The company focuses on developing products to treat an ocular eye dis
Drug Discovery
Boston, MA

New Haven, CT
 

Princeton, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nicox Ophthalmics Competitors (22)

One of Nicox Ophthalmics’s 22 competitors is Biohaven, a Formerly VC-backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biohaven Formerly VC-backed New Haven, CT
Bristol-Myers Squibb Corporation Princeton, NJ
Genentech Formerly VC-backed South San Francisco, CA
Incyte Formerly VC-backed Wilmington, DE
Agenus Formerly VC-backed Lexington, MA
You’re viewing 5 of 22 competitors. Get the full list »

Nicox Ophthalmics Patents

  • 52

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Nicox Ophthalmics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014107231-A1 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof Inactive 07-Jan-2013
JP-2015520149-A Hydrophobic therapeutic agent preparation, manufacturing method and use thereof Active 08-May-2012
WO-2013169647-A1 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof Inactive 08-May-2012
US-20120093876-A1 Ophthalmic formulations, methods of manufacture and methods of normalizing meibomian gland secretions Inactive 13-Oct-2010
WO-2012051313-A2 Ophthalmic formulations, methods of manufacture and methods of normalizing meibomian gland secretions Inactive 13-Oct-2010 A61K31/65
To view Nicox Ophthalmics’s complete patent history, request access »

Nicox Ophthalmics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Akorn Corporation Minority
Bay City Capital Venture Capital Minority
HealthCare Ventures Venture Capital Minority
New Enterprise Associates Venture Capital Minority
Ora Investment Group Corporate Venture Capital Minority
To view Nicox Ophthalmics’s complete investors history, request access »

Ready to get started?

Request a free trial

Nicox Ophthalmics FAQs

  • When was Nicox Ophthalmics founded?

    Nicox Ophthalmics was founded in 2007.

  • Where is Nicox Ophthalmics headquartered?

    Nicox Ophthalmics is headquartered in Boston, MA.

  • What industry is Nicox Ophthalmics in?

    Nicox Ophthalmics’s primary industry is Drug Discovery.

  • Is Nicox Ophthalmics a private or public company?

    Nicox Ophthalmics is a Private company.

  • What is the current valuation of Nicox Ophthalmics?

    The current valuation of Nicox Ophthalmics is .

  • What is Nicox Ophthalmics’s current revenue?

    The current revenue for Nicox Ophthalmics is .

  • How much funding has Nicox Ophthalmics raised over time?

    Nicox Ophthalmics has raised $47.3M.

  • Who are Nicox Ophthalmics’s investors?

    Akorn, Bay City Capital, HealthCare Ventures, New Enterprise Associates, and Ora Investment Group have invested in Nicox Ophthalmics.

  • Who are Nicox Ophthalmics’s competitors?

    Biohaven, Bristol-Myers Squibb, Genentech, Incyte, and Agenus are some of the 22 competitors of Nicox Ophthalmics.

  • When was Nicox Ophthalmics acquired?

    Nicox Ophthalmics was acquired on 28-Oct-2014.

  • Who acquired Nicox Ophthalmics?

    Nicox Ophthalmics was acquired by Nicox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process